Rivista
/
Genetica
/
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
JoVE Journal
Genetica
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Genetica
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

DOI:
10.3791/60085-v

•

09:04 min

•

September 25, 2019

•

, , ,
1Center for Cellular and Molecular Therapeutics,The Children’s Hospital of Philadelphia, 2Department of Pathology and Laboratory Medicine,The Children’s Hospital of Philadelphia, 3Department of Pathology and Laboratory Medicine,University of Pennsylvania

Capitoli

  • 00:04Titolo
  • 01:19Test gRNA (GuidE RNA) Cutting Efficiency
  • 03:50Clone Screening
  • 04:51Transfection Setup
  • 06:07Checking for Mutations in Single Colonies
  • 07:11Results: Cutting Efficiency, and Generation and Screening of Mutations
  • 08:10Conclusion

Summary

Traduzione automatica

Traduzione automatica

This protocol provides a method to facilitate the generation of defined heterozygous or homozygous nucleotide changes using CRISPR-CAS9 in human pluripotent stem cells.

Tags

CRISPR-Cas9Human Pluripotent Stem CellsIsogenic LinesHeterozygous MutationsGene FunctionDisease ModelingColony PickingFluorescence-activated Cell SortingMEFsROCK Inhibitor

Article

Embed

AGGIUNGI ALLA PLAYLIST

Usage Statistics

Video correlati

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells

Primordial Germ Cell Transplantation for CRISPR/Cas9-based Leapfrogging in Xenopus

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Read Article